959939-24-3

Upstream product

• 211693-73-1 2-amino-3,4-difluoronitro-benzene 

Downstream Products

• 959939-25-4 ethyl trans-4-(3-amino-2-fluoro-4-nitrophenoxy)cyclohexane-1-carboxylate 
• 959939-26-5 ethyl cis-4-(3-amino-2-fluoro-4-nitrophenoxy)cyclohexane-1-carboxylate 
• 1210047-88-3 3-amino-6-bromo-2-fluoro-4-nitrophenol 
• 1210047-74-7 2-fluoro-3-methoxy-6-nitroaniline 
• 1805115-08-5 2-fluoro-3-chloro-4-nitrophenol 
• 959939-27-6 ethyl cis-4-[2-fluoro-3-[(methoxycarbonylformyl)amino]-4-nitro-phenoxy]cyclohexane-1-carboxylate 
• 959939-28-7 ethyl cis-4-[2-fluoro-3-[(hydrazinecarbonylformyl)amino]-4-nitro-phenoxy]cyclohexane-1-carboxylate 

Relevant academic research and scientific papers

TYROSINE KINASE INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING SAME

The present invention relates to a tyrosine kinase inhibitor and a pharmaceutical composition comprising same. The tyrosine kinase inhibitor of the present invention has the structures as shown in the following formula (I) or (II):

SUBSTITUTED 5-AMINOPYRAZOLES AND USE THEREOF

The present application relates to novel substituted 5-aminopyrazoles, methods of production thereof, use thereof alone or in combinations for the treatment and/or prophylaxis of diseases and use thereof for the production of medicinal products for the treatment and/or prophylaxis of diseases.

BENZIMIDAZOLES AND THEIR USE FOR THE TREATEMNT OF DIABETES

Compounds of formula (I), or salts thereof, which inhibit acetyl CoA(acetyl coenzyme A):diacylglycerol acyltransferase (DGAT1) activity are provided, (A chemical formula should be inserted here - please see paper copy enclosed herewith) (I) wherein: Rsup